VIR insider filings

Vir Biotechnology, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-16. Screen VIR transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 6 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
de Verneuil Vanina — EVP, General Counsel, Corp Sec1—2 legs · 3,750 sh · $41,939—
Topalian Suzanne Louise — Director2——4
Sawaf Aziz — EVP, Chief Financial Officer2——2
Sabatini Brent — SVP, Chief Accounting Officer1——1

Recent insider filings — Vir Biotechnology, Inc.

FiledFormInsiderReported transactionsSource
2026-11-164Sabatini Brent — SVP, Chief Accounting OfficerGrant/award (A): 50,000 @ $0EDGAR
2026-11-164Sawaf Aziz — EVP, Chief Financial OfficerGrant/award (A): 75,000 @ $0 · Grant/award (A): 150,000 (derivative) @ $0EDGAR
2026-11-044de Verneuil Vanina — EVP, General Counsel, Corp SecSale (S): 1,343 @ $11.33 · Sale (S): 2,407 @ $11.10EDGAR
2026-10-284Topalian Suzanne Louise — DirectorGrant/award (A): 8,000 @ $0 · Grant/award (A): 4,731 @ $0 · Grant/award (A): 16,000 (derivative) @ $0 · Grant/award (A): 9,462 (derivative) @ $0EDGAR
2026-10-283Topalian Suzanne Louise — DirectorHoldings only — no transactions reportedEDGAR
2026-10-063Sawaf Aziz — EVP, Chief Financial OfficerHoldings only — no transactions reportedEDGAR
2026-08-124MORE ROBERT J — DirectorOther (J): 8,000 @ $0 · Other (J): 8,000 @ $0EDGAR
2026-06-104Coughlin Timothy — DirectorGrant/award (A): 8,000 @ $0 · Grant/award (A): 8,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0 · Grant/award (A): 16,000 (derivative) @ $0EDGAR
2026-06-024Napolitano Janet — DirectorSale (S): 3,200 @ $9.45EDGAR
2026-06-024Sabatini Brent — SVP, Chief Accounting OfficerSale (S): 379 @ $9.45EDGAR
2026-05-284Napolitano Janet — DirectorGrant/award (A): 8,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0EDGAR
2026-05-284Farid Ramy — DirectorGrant/award (A): 8,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0EDGAR
2026-05-284Sigal Charles Elliott — DirectorGrant/award (A): 8,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0EDGAR
2026-05-284Hatfield Jeffrey S. — DirectorGrant/award (A): 8,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0EDGAR
2026-05-284MORE ROBERT J — DirectorGrant/award (A): 8,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0EDGAR
2026-05-284BISCHOFBERGER NORBERT W — DirectorGrant/award (A): 8,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0EDGAR
2026-05-044SATO VICKI L — DirectorSale (S): 22,000 @ $10.05EDGAR
2026-04-304De Backer Marianne — President and CEO, DirectorOther (J): 233,532 @ $0 · Other (J): 233,532 @ $0EDGAR
2026-04-074De Backer Marianne — President and CEO, DirectorSale (S): 72,559 @ $9.16EDGAR
2026-04-024SATO VICKI L — DirectorSale (S): 22,000 @ $9.07EDGAR
2026-03-244Sabatini Brent — SVP, Chief Accounting OfficerSale (S): 7,711 @ $9.12EDGAR
2026-03-234O'Byrne Jason — EVP & Chief Financial OfficerOther (J): 2,500 @ $0 · Other (J): 2,500 @ $0EDGAR
2026-03-034SATO VICKI L — DirectorSale (S): 21,800 @ $9.50 · Sale (S): 200 @ $9.98EDGAR
2026-02-264Sabatini Brent — SVP, Chief Accounting OfficerSale (S): 1,430 @ $9.53EDGAR
2026-02-264O'Byrne Jason — EVP & Chief Financial OfficerSale (S): 1,634 @ $9.53EDGAR
2026-02-264Eisner Mark — EVP and Chief Medical OfficerSale (S): 1,616 @ $9.53 · Sale (S): 1,889 @ $9.82EDGAR
2026-02-264de Verneuil Vanina — EVP, General Counsel, Corp SecSale (S): 3,117 @ $9.53 · Sale (S): 13,700 @ $9.82EDGAR
2026-02-264De Backer Marianne — Chief Executive Officer, DirectorSale (S): 14,762 @ $9.53EDGAR
2026-02-264SATO VICKI L — DirectorOption exercise (M): 42,377 @ $1.49 · Sale (S): 42,177 @ $9.75 · Sale (S): 200 @ $10.26 · Option exercise (M): 42,377 (derivative) @ $0EDGAR
2026-02-244Sabatini Brent — SVP, Chief Accounting OfficerGrant/award (A): 25,000 @ $0 · Sale (S): 1,829 @ $7.45 · Grant/award (A): 50,000 (derivative) @ $0EDGAR
2026-02-244O'Byrne Jason — EVP & Chief Financial OfficerGrant/award (A): 55,000 @ $0 · Sale (S): 2,089 @ $7.45 · Grant/award (A): 110,000 (derivative) @ $0EDGAR
2026-02-244Eisner Mark — EVP and Chief Medical OfficerGrant/award (A): 55,000 @ $0 · Sale (S): 2,089 @ $7.45 · Grant/award (A): 110,000 (derivative) @ $0EDGAR
2026-02-244de Verneuil Vanina — EVP, General Counsel, Corp SecGrant/award (A): 55,000 @ $0 · Sale (S): 4,445 @ $7.45 · Grant/award (A): 110,000 (derivative) @ $0EDGAR
2026-02-244De Backer Marianne — Chief Executive Officer, DirectorGrant/award (A): 285,000 @ $0 · Sale (S): 19,039 @ $7.45 · Grant/award (A): 570,000 (derivative) @ $0EDGAR
2026-02-184Sabatini Brent — SVP, Chief Accounting OfficerSale (S): 1,530 @ $7.79EDGAR
2026-02-034SATO VICKI L — DirectorSale (S): 22,000 @ $7.71EDGAR
2026-01-054SATO VICKI L — DirectorSale (S): 22,000 @ $5.93EDGAR
2025-12-034SVF Endurance (Cayman) Ltd — 10% owner
SOFTBANK VISION FUND (AIV M1) L.P. — 10% owner
SB INVESTMENT ADVISERS (UK) LTD — 10% owner
Sale (S): 191,854 @ $5.98EDGAR
2025-12-024SATO VICKI L — DirectorSale (S): 22,000 @ $6.00EDGAR
2025-12-014SVF Endurance (Cayman) Ltd — 10% owner
SOFTBANK VISION FUND (AIV M1) L.P. — 10% owner
SB INVESTMENT ADVISERS (UK) LTD — 10% owner
Sale (S): 127,938 @ $6.39 · Sale (S): 61,493 @ $6.44EDGAR
2025-11-264SVF Endurance (Cayman) Ltd — 10% owner
SOFTBANK VISION FUND (AIV M1) L.P. — 10% owner
SB INVESTMENT ADVISERS (UK) LTD — 10% owner
Sale (S): 227,803 @ $6.15 · Sale (S): 235,971 @ $6.38EDGAR
2025-11-184O'Byrne Jason — EVP & Chief Financial OfficerSale (S): 6,799 @ $5.56EDGAR
2025-11-074de Verneuil Vanina — EVP, General Counsel, Corp SecSale (S): 2,385 @ $5.16EDGAR
2025-11-044de Verneuil Vanina — EVP and General CounselSale (S): 1,365 @ $5.86EDGAR
2025-11-044SATO VICKI L — DirectorSale (S): 22,000 @ $5.64EDGAR
2025-10-304SVF Endurance (Cayman) Ltd — 10% owner
SOFTBANK VISION FUND (AIV M1) L.P. — 10% owner
SB INVESTMENT ADVISERS (UK) LTD — 10% owner
Sale (S): 24,453 @ $6.50 · Sale (S): 100 @ $6.49EDGAR
2025-10-284SVF Endurance (Cayman) Ltd — 10% owner
SOFTBANK VISION FUND (AIV M1) L.P. — 10% owner
SB INVESTMENT ADVISERS (UK) LTD — 10% owner
Sale (S): 46,696 @ $5.96 · Sale (S): 66,403 @ $6.05EDGAR
2025-10-244SVF Endurance (Cayman) Ltd — 10% owner
SOFTBANK VISION FUND (AIV M1) L.P. — 10% owner
SB INVESTMENT ADVISERS (UK) LTD — 10% owner
Sale (S): 144,266 @ $6.15 · Sale (S): 154,383 @ $5.99EDGAR
2025-10-224SVF Endurance (Cayman) Ltd — 10% owner
SOFTBANK VISION FUND (AIV M1) L.P. — 10% owner
SB INVESTMENT ADVISERS (UK) LTD — 10% owner
Sale (S): 220,535 @ $6.20 · Sale (S): 109,675 @ $6.30EDGAR
2025-10-174SVF Endurance (Cayman) Ltd — 10% owner
SOFTBANK VISION FUND (AIV M1) L.P. — 10% owner
SB INVESTMENT ADVISERS (UK) LTD — 10% owner
Sale (S): 16,671 @ $6.07 · Sale (S): 12,844 @ $6.10EDGAR

Recent 8-K events — Vir Biotechnology, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-168-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-098-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-048-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-288-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-10-148-K3.02 — Unregistered Sales of Equity Securities
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-088-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-018-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-248-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-06-108-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=VIR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs